Investing

Today's Market Winners and Losers

Wikimedia Creative Commons, JohnnyMrNinja
The stock market is down Tuesday, with the Dow Jones Industrial Average down 0.60%, the Nasdaq down 0.44% and the S&P 500 down 0.56%. Today’s winners both include mergers, while today’s loser sank due to a major competitor securing an exclusive licensing deal.

Here are Tuesday’s market winners and loser.

Biggest Winners

Shares of Medicis Pharmaceutical Corp. (NYSE: MRX) are up 37.90% to $43.52 on trading volume of 19.4 million shares. Valeant Pharmaceuticals International Inc. (NYSE: VRX) has agreed to buy Medicis for $2.6 billion. Before Tuesday, the 52-week high was $40.10.

Shares of Heckmann Corp. (NYSE: HEK) are up 20.45% to $3.24 on trading volume of 5.7 million shares. The company announced its intentions to buy Power Fuels for $380.5 million in cash, debt and stock. The 52-week high is $7.05.

Biggest Loser

Shares of Netflix Inc. (NASDAQ: NFLX) are down 10.92% to $53.20 on trading volume of 4.1 million shares. Rival Amazon.com Inc. (NASDAQ: AMZN) has signed a content deal to add EPIX movies to Prime streaming. The 52-week low is $52.81.

Samuel Weigley

Follow him on Twitter: SWeigley

Is Your Money Earning the Best Possible Rate? (Sponsor)

Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.

However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.

There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.